middle.news
Starpharma and Genentech Forge $569M Oncology Collaboration
9:05am on Monday 22nd of September, 2025 AEST
•
Biotechnology
Read Story
Starpharma and Genentech Forge $569M Oncology Collaboration
9:05am on Monday 22nd of September, 2025 AEST
Key Points
Collaboration and license agreement with Genentech
Use of Starpharma’s proprietary DEP® platform for oncology drug development
Upfront payment of USD 5.5 million (~AUD 8.3 million)
Potential milestone payments up to USD 564 million (~AUD 855 million)
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
SPL
OPEN ARTICLE